Vanguard Investments Australia’s Novavax NVAX Stock Holding History

Vanguard Investments Australia’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$314K	Hold	33,286	–	–	﹤0.01%	1909
2026 Q1	$271K	Buy	+33,286	New	+$302K	﹤0.01%	1894

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Vanguard Investments Australia's NVAX Position: Q2 2026 in Review

Vanguard Investments Australia held its Novavax (NVAX) position steady in Q2 2026 at 33,286 shares worth $314K. The position accounts for ﹤0.01% of the portfolio, ranked #1909.

Vanguard Investments Australia first reported a position in NVAX in Q1 2026 and has held it in 2 quarters since. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

Vanguard Investments Australia held 33,286 shares of Novavax worth $314K as of Q2 2026.
Vanguard Investments Australia left its Novavax share count unchanged in Q2 2026.
Novavax made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #1909 holding.
Vanguard Investments Australia first reported a position in Novavax in Q1 2026 and has held it in 2 quarters since.
266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.